Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorDoggui, Radhouene
dc.contributor.authorAdib, Keyrellous
dc.contributor.authorBaldacchino, Alexander Mario
dc.date.accessioned2021-10-13T10:30:06Z
dc.date.available2021-10-13T10:30:06Z
dc.date.issued2021-09-28
dc.identifier.citationDoggui , R , Adib , K & Baldacchino , A M 2021 , ' Understanding fatal and non-fatal drug overdose risk factors : overdose risk questionnaire pilot study—validation ' , Frontiers in Pharmacology , vol. 12 , 693673 . https://doi.org/10.3389/fphar.2021.693673en
dc.identifier.issn1663-9812
dc.identifier.otherPURE: 275239840
dc.identifier.otherPURE UUID: 2f2ca35f-4f7a-4ced-870e-20ab44cd2fcc
dc.identifier.otherORCID: /0000-0002-5388-7376/work/101581534
dc.identifier.otherScopus: 85117150442
dc.identifier.otherWOS: 000706304000001
dc.identifier.urihttps://hdl.handle.net/10023/24116
dc.descriptionData collection and analysis was supported by the Health Informatics Centre, Farr Institute, the University of Dundee. In addition, NHS Fife R&D, NHS Education for Scotland, and the Medical School of the University of St Andrews supported the project.en
dc.description.abstractBackground: Drug overdoses (fatal and non-fatal) are among the leading causes of death in population with substance use disorders. The aim of the current study was to identify risk factors for fatal and non-fatal drug overdose for predominantly opioid-dependent treatment–seeking population. Methods: Data were collected from 640 adult patients using a self-reported 25-item Overdose Risk (OdRi) questionnaire pertaining to drug use and identified related domains. The exploratory factor analysis (EFA) was primarily used to improve the interpretability of this questionnaire. Two sets of EFA were conducted; in the first set of analysis, all items were included, while in the second set, items related to the experience of overdose were removed. Logistic regression was used for the assessment of latent factors’ association with both fatal and non-fatal overdoses. Results: EFA suggested a three-factor solution accounting for 75 and 97% of the variance for items treated in the first and second sets of analysis, respectively. Factor 1 was common for both sets of EFA analysis, containing six items (Cronbach’s α = 0.70) focusing around “illicit drug use and lack of treatment.” In the first set of analysis, Factors 2 (Cronbach’s α = 0.60) and 3 (Cronbach’s α = 0.34) were focusing around “mental health and emotional trauma” and “chronic drug use and frequent overdose” domains, respectively. The increase of Factor 2 was found to be a risk factor for fatal drug overdose (adjusted coefficient = 1.94, p = 0.038). In the second set of analysis, Factors 2 (Cronbach’s α = 0.65) and 3 (Cronbach’s α = 0.59) as well as Factor 1 were found to be risk factors for non-fatal drug overdose ever occurring. Only Factors 1 and 3 were positively associated with non-fatal overdose (one in a past year). Conclusion: The OdRi tool developed here could be helpful for clinical studies for the overdose risk assessment. However, integrating validated tools for mental health can probably help refining the accuracy of latent variables and the questionnaire’s consistency. Mental health and life stress appear as important predictors of both fatal and non-fatal overdoses.
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofFrontiers in Pharmacologyen
dc.rightsCopyright © 2021 Doggui, Adib and Baldacchino. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.en
dc.subjectFatal overdoseen
dc.subjectExploratory factor analysisen
dc.subjectRisk factorsen
dc.subjectAdultsen
dc.subjectScotlanden
dc.subjectBF Psychologyen
dc.subjectRC0321 Neuroscience. Biological psychiatry. Neuropsychiatryen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject3rd-DASen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subject.lccBFen
dc.subject.lccRC0321en
dc.subject.lccRMen
dc.titleUnderstanding fatal and non-fatal drug overdose risk factors : overdose risk questionnaire pilot study—validationen
dc.typeJournal articleen
dc.description.versionPublisher PDFen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Centre for Minorities Research (CMR)en
dc.contributor.institutionUniversity of St Andrews. Population and Behavioural Science Divisionen
dc.identifier.doihttps://doi.org/10.3389/fphar.2021.693673
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record